Back to search

Aristotle University Of Thessaloniki (AUTH)

Επίδραση της δεξμετομιδίνης στην εγκεφαλική ομοιοστασία και στην νευρογνωσιακή έκβαση ασθενών που υποβάλλονται σε εξαίρεση όγκων εγκεφάλου

Abstract

dc:description

Optimization and maintenance of cerebral homeostasis constitute a cornerstone of anesthetic management during brain tumor surgery, aiming to minimize secondary brain injury. Furthermore, surgical manipulations during craniotomy procedures are expected to compromise cerebral oxygenation and metabolism in the affected brain area. The delicate balance between oxygen supply and demand is crucial for maintaining cerebral homeostasis. Biochemical markers of neuronal injury provide valuable information regarding the extent of neuronal damage and prognosis. Among the most reliable biomarkers are S100B protein and neuron-specific enolase (NSE). Dexmedetomidine is an α2-adrenergic receptor agonist that appears to reduce levels of pro-inflammatory cytokines and its administration appears to be an attractive option due to its potential neuroprotective properties. Aim of the study was to investigate the effect of dexmedetomidine on inflammatory biomarkers, brain oxygenation and metabolism/ homeostasis, and neurocognitive function when used as an anesthetic adjuvant in patients undergoing craniotomy for brain tumor excision. For this purpose, 56 patients scheduled to undergo elective craniotomy for brain tumor excision, were enrolled in the study. Patients were randomized using a computer-generated randomization table to group A (dexmedetomidine) or group B (placebo). Hemodynamic status (heart rate, mean arterial pressure, central venous pressure, cardiac index, stroke volume variation, stroke volume index and systemic vascular resistance index), brain damage biomarkers (S100B, NSE) and inflammatory biomarkers (IL-6, TNF-α, cortisol, glucose) concentrations 5 minutes before intervention, 6 hours and 24 hours after surgery completion, brain oxygenation status, assessed with parameters derived from blood gases from the jugular bulb (PjO₂,PjCO₂,SjO₂) along with calculated parameters (AjDO₂,AjDCO₂,O₂ERbr,eRQbr) and neurocognitive status assessed by MMSE, MoCA and ACE-III score preoperatively, 7 days and 1 month after surgery were evaluated. Statistical analysis was performed using the two-factor mixed ANOVA for repeated measures together with the Greenhouse-Geisser correction, Friedman’s test, Student’s t-test for independent samples, Mann-Whitney U-test, Chi-square test and Fischer’s exact test. Statistical analysis was performed using the SPSS 29.0. Demographic and perioperative characteristics were comparable between groups. Propofol consumption was considerably reduced in group A patients (p<0.001). Intraoperative administration of dexmedetomidine resulted in the attenuation of S100B, NSE, IL-6, TNF-α and cortisol levels in blood samples at 6 and 24 hours after surgery completion (p<0,01). Hemodynamic stability was recorded throughout the surgical procedure, with an increase in systemic vascular resistance and mean arterial pressure after bolus dexmedetomidine infusion being the only exceptions. Simultaneously, a transient improvement of cerebral oxygenation was recorded. Finally, dexmedetomidine administration exerted no notable effect on postoperative neurocognitive status, as assessed by MMSE, MoCA and ACE-III score. In conclusion, the implementation of dexmedetomidine in standard anesthesia practice during brain tumor excision is associated with reduced release of brain injury and neuroinflammation biomarkers, along with transient improvements in hemodynamic stability and cerebral oxygenation following bolus administration. Nonetheless, the observed differences in circulating biomarkers should be interpreted cautiously, as they do not demonstrate clinically meaningful neuroprotection in the absence of improved patient outcomes. Furthermore, the impact of dexmedetomidine infusion on cerebral homeostasis preservation could be endangered by adverse systemic hemodynamic responses at high-dose regimens.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nikopoulou, Anastasia
  • Νικοπούλου, Αναστασία

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62263

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nikopoulou, Anastasia; Νικοπούλου, Αναστασία. Επίδραση της δεξμετομιδίνης στην εγκεφαλική ομοιοστασία και στην νευρογνωσιακή έκβαση ασθενών που υποβάλλονται σε εξαίρεση όγκων εγκεφάλου. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/62263